Multidisciplinary care

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Optimal multidisciplinary care of the lung cancer patient at all stages should encompass integration of the key relevant medical specialties, including not only medical, surgical, and radiation oncology, but also pulmonology, interventional and diagnostic radiology, pathology, palliative care, and supportive services such as physical therapy, case management, smoking cessation, and nutrition. Multidisciplinary management starts at staging and tissue diagnosis with pathologic and molecular phenotyping, extends through selection of a treatment modality or modalities, management of treatment and cancer-related symptoms, and to survivorship and end-of-life care. Well-integrated multidisciplinary care may reduce treatment delays, improve cancer-specific outcomes, and enhance quality of life. We address key topics and areas of ongoing investigation in multidisciplinary decision making at each stage of the lung cancer treatment course for early-stage, locally advanced, and metastatic lung cancer patients.

Original languageEnglish (US)
Title of host publicationCancer Treatment and Research
PublisherKluwer Academic Publishers
Pages285-300
Number of pages16
Volume170
DOIs
StatePublished - 2016

Publication series

NameCancer Treatment and Research
Volume170
ISSN (Print)09273042

Fingerprint

Lung Neoplasms
Interventional Radiology
Pulmonary Medicine
Radiation Oncology
Terminal Care
Medical Oncology
Second Primary Neoplasms
Case Management
Smoking Cessation
Therapeutics
Palliative Care
Decision Making
Survival Rate
Quality of Life
Medicine
Pathology
Neoplasms
Surgical Oncology

Keywords

  • Integrated care
  • Multidisciplinary care
  • Multimodality treatment
  • Non-small cell lung cancer

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

Cite this

Daly, M. E., & Riess, J. (2016). Multidisciplinary care. In Cancer Treatment and Research (Vol. 170, pp. 285-300). (Cancer Treatment and Research; Vol. 170). Kluwer Academic Publishers. https://doi.org/10.1007/978-3-319-40389-2_13

Multidisciplinary care. / Daly, Megan E; Riess, Jonathan.

Cancer Treatment and Research. Vol. 170 Kluwer Academic Publishers, 2016. p. 285-300 (Cancer Treatment and Research; Vol. 170).

Research output: Chapter in Book/Report/Conference proceedingChapter

Daly, ME & Riess, J 2016, Multidisciplinary care. in Cancer Treatment and Research. vol. 170, Cancer Treatment and Research, vol. 170, Kluwer Academic Publishers, pp. 285-300. https://doi.org/10.1007/978-3-319-40389-2_13
Daly ME, Riess J. Multidisciplinary care. In Cancer Treatment and Research. Vol. 170. Kluwer Academic Publishers. 2016. p. 285-300. (Cancer Treatment and Research). https://doi.org/10.1007/978-3-319-40389-2_13
Daly, Megan E ; Riess, Jonathan. / Multidisciplinary care. Cancer Treatment and Research. Vol. 170 Kluwer Academic Publishers, 2016. pp. 285-300 (Cancer Treatment and Research).
@inbook{8c0642bf8790417a80bdeb1e27833391,
title = "Multidisciplinary care",
abstract = "Optimal multidisciplinary care of the lung cancer patient at all stages should encompass integration of the key relevant medical specialties, including not only medical, surgical, and radiation oncology, but also pulmonology, interventional and diagnostic radiology, pathology, palliative care, and supportive services such as physical therapy, case management, smoking cessation, and nutrition. Multidisciplinary management starts at staging and tissue diagnosis with pathologic and molecular phenotyping, extends through selection of a treatment modality or modalities, management of treatment and cancer-related symptoms, and to survivorship and end-of-life care. Well-integrated multidisciplinary care may reduce treatment delays, improve cancer-specific outcomes, and enhance quality of life. We address key topics and areas of ongoing investigation in multidisciplinary decision making at each stage of the lung cancer treatment course for early-stage, locally advanced, and metastatic lung cancer patients.",
keywords = "Integrated care, Multidisciplinary care, Multimodality treatment, Non-small cell lung cancer",
author = "Daly, {Megan E} and Jonathan Riess",
year = "2016",
doi = "10.1007/978-3-319-40389-2_13",
language = "English (US)",
volume = "170",
series = "Cancer Treatment and Research",
publisher = "Kluwer Academic Publishers",
pages = "285--300",
booktitle = "Cancer Treatment and Research",

}

TY - CHAP

T1 - Multidisciplinary care

AU - Daly, Megan E

AU - Riess, Jonathan

PY - 2016

Y1 - 2016

N2 - Optimal multidisciplinary care of the lung cancer patient at all stages should encompass integration of the key relevant medical specialties, including not only medical, surgical, and radiation oncology, but also pulmonology, interventional and diagnostic radiology, pathology, palliative care, and supportive services such as physical therapy, case management, smoking cessation, and nutrition. Multidisciplinary management starts at staging and tissue diagnosis with pathologic and molecular phenotyping, extends through selection of a treatment modality or modalities, management of treatment and cancer-related symptoms, and to survivorship and end-of-life care. Well-integrated multidisciplinary care may reduce treatment delays, improve cancer-specific outcomes, and enhance quality of life. We address key topics and areas of ongoing investigation in multidisciplinary decision making at each stage of the lung cancer treatment course for early-stage, locally advanced, and metastatic lung cancer patients.

AB - Optimal multidisciplinary care of the lung cancer patient at all stages should encompass integration of the key relevant medical specialties, including not only medical, surgical, and radiation oncology, but also pulmonology, interventional and diagnostic radiology, pathology, palliative care, and supportive services such as physical therapy, case management, smoking cessation, and nutrition. Multidisciplinary management starts at staging and tissue diagnosis with pathologic and molecular phenotyping, extends through selection of a treatment modality or modalities, management of treatment and cancer-related symptoms, and to survivorship and end-of-life care. Well-integrated multidisciplinary care may reduce treatment delays, improve cancer-specific outcomes, and enhance quality of life. We address key topics and areas of ongoing investigation in multidisciplinary decision making at each stage of the lung cancer treatment course for early-stage, locally advanced, and metastatic lung cancer patients.

KW - Integrated care

KW - Multidisciplinary care

KW - Multimodality treatment

KW - Non-small cell lung cancer

UR - http://www.scopus.com/inward/record.url?scp=84983739020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983739020&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-40389-2_13

DO - 10.1007/978-3-319-40389-2_13

M3 - Chapter

C2 - 27535399

AN - SCOPUS:84983739020

VL - 170

T3 - Cancer Treatment and Research

SP - 285

EP - 300

BT - Cancer Treatment and Research

PB - Kluwer Academic Publishers

ER -